Global chest drainage system sales are projected to exhibit Y-o-Y growth of 5.7% in 2023, totaling US$ 1,034.25 million. Over the assessment period, chest drainage system demand is predicted to rise at a CAGR of 5.7%. By 2033, the global chest drainage system market size is set to reach US$ 1,795.93 million.
| Attributes | Key Insights |
|---|---|
| Global Chest Drainage System Market Revenue (2022) | US$ 977.91 million |
| Estimated Chest Drainage System Market Size (2023) | US$ 1,034.25 million |
| Projected Chest Drainage System Market Value (2033) | US$ 1,795.93 million |
| Chest Drainage System Value CAGR (2023 to 2033) | 5.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Market to Expand 1.7X through 2033
The global chest drainage system market is projected to expand 1.7X through 2033, amid a 1.4% increase in estimated CAGR compared to the historical one. This is attributable to rising cases of cardiovascular diseases, expanding healthcare facilities, growing health awareness, and favorable government policies.
Pleural Drainage Systems to Generate Substantial Revenue
As per the latest report, pleural drainage systems segment is expected to hold a prominent share in terms of product. This is due to rising demand for pleural drainage systems, also known as chest tube drainage systems, from hospitals, specialty clinics, and ambulatory surgical centers.
The management of thoracic and respiratory disorders, including pneumothorax, pleural effusion, and empyema, depends heavily on pleural drainage systems. They are gaining wider popularity among end users for draining the pleural space.
Pleural drainage systems, especially digital ones, are widely used to remove blood, air, and other fluids from the pleural space. Growing demand for pleural cavity drainage systems from hospitals and other healthcare settings will boost the target segment. Key manufacturers will likely expand their pleural drainage system portfolios to gain maximum profits.
North America to Nearly Account 28% Sales through 2033
North America is predicted to remain the leading consumer of chest drainage systems during the assessment period. It will likely contribute about 28% of global sales by 2033. This is attributable to factors such as,
Chest drainage systems, or thoracic or chest tube drainage systems, have become essential chest drainage management solutions. They are a highly preferred choice by medical professionals for removing fluid, blood, or air from the pleural space or pleural cavity.
Demand for chest drainage systems is expected to rise rapidly during the forecast period. This is due to factors like rising cases of respiratory conditions, expanding healthcare infrastructure, and growing popularity of advanced digital drainage systems (DDS) in chest drainage management.
Chest drainage systems are the preferred mode of treatment opted for by patients for diseases including pneumothorax, hemothorax, and pleural effusion. Rising incidence of these diseases will likely create revenue-generation opportunities for chest drainage system manufacturers.
Principal Consultant
| Historical CAGR (2018 to 2022) | 4.3% |
|---|---|
| Forecast CAGR (2023 to 2033) | 5.7% |
Global sales of chest drainage systems grew at a CAGR of 4.3% in the last five years, from 2017 to 2022. They account for around 36.8% of global surgical drainage device sales. Total chest drainage system revenue reached about US$ 977.91 million in 2022.
Over the forecast period, chest drainage system demand is anticipated to rise at a CAGR of 5.7%. By 2033, the worldwide chest drainage system market value is set to reach US$ 1,795.93 million by 2033. This is due to rising cases of cardiovascular and respiratory diseases, expanding healthcare infrastructure, and surging popularity of advanced chest drainage management devices.
Cardiovascular disease (CVD) is prevalent and one of the leading causes of death worldwide, claiming an estimated 17.9 million lives each year. Chest drainage devices are predicted to become more popular as the healthcare industry seeks to combat cardiovascular illnesses' rising prevalence and recurrence.
The World Health Organization (WHO) estimates that 17.9 million people died from cardiovascular diseases (CVDs) in 2019, accounting for 32% of all fatalities. Heart attacks and strokes were to blame for 85% of these fatalities. This positively impacts chest drainage system sales, and the trend is expected to continue through 2033.
The prevalence of congestive heart failure (CHF) is expected to increase, with researchers predicting around 46% increase in the rate of heart failure prevalence by 2030. This will create a high demand for medical devices like chest drainage systems.
Integration of digital technologies into chest drainage systems
The integration of digital technologies into chest drainage systems is gaining momentum. Sales are gaining momentum for systems equipped with digital sensors and interfaces that enable real-time monitoring and data collection.
Digitalization enhances clinical decision-making by providing objective data on air leaks, fluid drainage, and patient status. Digital chest drainage systems allow medical professionals to accurately monitor patients’ drainage levels and adjust the system settings remotely. This can help to reduce the number of hospital stays and enhance patient outcomes.
Rise in surgical procedures
More patients opting for surgical procedures, especially cardiac and thoracic surgeries, are expected to boost the global chest drainage system market. These systems are renowned for efficient post-operative fluid accumulation management and lung function maintenance.
Integration of digital technologies into chest drainage systems
The integration of digital technologies into chest drainage systems is gaining momentum. These systems now often come equipped with digital sensors and interfaces that enable real-time monitoring and data collection. Digitalization enhances clinical decision-making by providing objective data on air leaks, fluid drainage, and patient status.
Rising popularity of renewable chest drainage systems
The trend is toward reusable chest drainage systems that reduce medical waste and environmental impact. These systems are designed for longevity and are made of materials that can withstand multiple sterilization cycles. Reusable systems meet sustainability goals and offer long-term cost savings, making them an attractive option for healthcare facilities.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Increasing demand for minimally invasive approaches
Advances in medical technology are making minimally invasive chest drainage procedures more accessible and practical. These innovations include developing specialized equipment and techniques that allow healthcare providers to perform precise procedures with smaller incisions.
Integrating digital solutions further enhances the precision and monitoring of minimally invasive chest drainage. Minimally invasive approaches often involve smaller incisions and reduced exposure to external contaminants, leading to a lower risk of infection. Infection control is a paramount concern in healthcare settings, and this trend addresses that concern effectively.
Minimally invasive procedures, such as thoracentesis and video-assisted thoracoscopic surgery (VATS), are commonly used to diagnose and treat pleural effusion. Rise in their procedures is expected to drive demand for chest drainage systems as they play a crucial role by facilitating the safe and effective removal of fluid or air from the pleural cavity.
Transition towards next-generation chest drainage systems
The rising popularity of advanced solutions like smart chest drainage systems is expected to grow the chest drainage systems market. Smart’ or ‘connected’ chest drainage systems leverage advanced technology and connectivity to enhance patient care, streamline medical procedures, and improve healthcare outcomes.
Smart chest drainage systems are equipped with sensors and digital interfaces, allowing continuous, real-time monitoring of various parameters. This is a key factor boosting its demand since it allows for convenient monitoring of air leaks, fluid drainage rates, and pressure within the pleural cavity. Several smart chest drainage systems are designed with wireless connectivity options. This enables healthcare providers to monitor patient data through secure digital platforms remotely. Physicians can access vital information from their smartphones or computers, improving the efficiency of care.
The recent recommendation by the National Institute for Health and Care Excellence (NICE) to adopt Thopaz+ for chest drainage systems presents a substantial opportunity for growth in this business. NICE's endorsement, supported by cost modeling, indicates significant cost savings when using Thopaz+ compared to conventional systems. The estimated potential annual savings in the United States is expected to amount to about US$ 11.6 million. These savings primarily stem from reduced hospital stays, a critical factor in healthcare expenditures.
By shortening the drainage time and streamlining the length of patient hospitalization, Thopaz+ leads to financial efficiencies and enhances patient safety through continuous and objective monitoring of air leaks and fluid loss. This real-time monitoring allows healthcare professionals to intervene promptly, resulting in better patient management and potentially avoiding costly complications.
The endorsement of Thopaz+ encourages standardization of treatment protocols across wards, which can contribute to improved patient outcomes and more efficient healthcare delivery. Thopaz+ also equips clinicians with objective data, thereby enhancing clinical decision-making.
Lastly, the system promotes increased patient mobility, positively impacting patient satisfaction and overall recovery. The adoption of Thopaz+ not only represents substantial cost savings but also signifies an opportunity to elevate the quality of patient care, streamline healthcare processes, and promote innovative technology in improving healthcare outcomes while optimizing healthcare costs.
The chest drainage system market faces a significant restraint in the form of a shortage of skilled healthcare professionals and the critical need for comprehensive training and education. Inefficient utilization of chest drainage systems, a direct consequence of inadequate training, will lead to suboptimal patient care and potentially life-threatening complications.
Safety concerns loom large as healthcare professionals struggle with the complexities of chest drainage technology, including setup, management, and troubleshooting. This lack of expertise hinders the full realization of the potential of advanced chest drainage systems and contributes to the delayed adoption of innovative solutions that could otherwise enhance patient care and outcomes.
Maintenance challenges further underscore the significance of this restraint, as the routine care, calibration, and timely troubleshooting of chest drainage systems necessitate knowledgeable personnel. Without skilled healthcare professionals, equipment downtime becomes a looming threat, potentially causing interruptions in patient care and exacerbating the challenges faced by healthcare institutions.
| Particulars | Value CAGR |
|---|---|
| Pleural Cavity Drainage Industry Outlook | 5.1% |
| Surgical Drainage Device Industry Outlook | 7.7% |
| Pleural Diseases Therapeutics Industry Outlook | 6.5% |
The table below highlights key countries’ chest drainage system market revenue. China, India, and the United States are expected to remain top markets for chest drainage systems, with expected valuations of US$ 189.49 million, US$ 176.50 million, and US$ 478.19 million, respectively, in 2033.
| Countries | Market Value (2033) |
|---|---|
| United States | US$ 478.19 million |
| United Kingdom | US$ 48.94 million |
| China | US$ 189.49 million |
| Japan | US$ 116.40 million |
| Germany | US$ 80.91 million |
| India | US$ 176.50 million |
| South Korea | US$ 16.80 million |
Below table shows the estimated growth rates of top five countries. South Korea and Japan are set to record higher CAGRs of 10.4% and 9.7%, respectively, through 2033.
Market Growth Outlook by Key Countries
| Country | Value CAGR |
|---|---|
| United States | 3.6% |
| Germany | 3.5% |
| United Kingdom | 5.3% |
| Japan | 9.7% |
| China | 7.2% |
| South Korea | 10.4% |
| India | 7.1% |
The United States chest drainage system market is expected to register a CAGR of 3.6% during the forecast period. It is predicted to attain a valuation of US$ 478.19 million by 2033. Rapid expansion of healthcare infrastructure and growing prevalence of diseases like pneumothorax are uplifting chest drainage system demand.
The increasing prevalence of pneumothorax characterizes a notable trend in the chest drainage system market. In the United States alone, the annual incidence of primary spontaneous pneumothorax (PSP) is 7 cases per 100,000 men and 1 per 100,000 women, with recurrence rates ranging from 25% to 50%.
Secondary spontaneous pneumothorax (SSP) is also increasing. This is especially true for the elderly, aged 60 to 65, with an incidence of 6.3 cases per 100,000 men and 2 cases per 100,000 women. This trend underscores the urgent need for effective chest drainage systems to treat the increasing cases of pneumothorax, thereby driving demand.
The prevalence of pneumothorax exhibits gender and age disparities, with men being more susceptible than women in the United States. The male-to-female ratio is 3:1 for secondary spontaneous pneumothorax (SSP), highlighting the importance of tailoring solutions to different patient demographics.
As the aging population continues to increase, the incidence of pneumothorax in the elderly is expected to increase demand for chest drainage systems further. This will likely boost sales and improve the market share of the United States chest drainage system.
China is projected to continue experiencing high growth throughout the forecast period. As per the latest report, China chest drainage system market is set to register a CAGR of 7.2% throughout the forecast period. By 2033, total revenue in China is predicted to reach US$ 189.49 million.
In China, the prevalence of respiratory illnesses like pneumonia, lung cancer, and tuberculosis is on the rise, and this is a key driver for chest drainage system sales. Chest drainage techniques are frequently needed to treat and diagnose these illnesses.
Due to an increased geriatric population, respiratory illnesses and other chest-related health problems are becoming common in China. The demand for chest drainage devices is projected to rise as the older population increases.
According to a recent piece of Chinese literature, China has 2.5 million cases of pneumonia annually, and 125,000 (5%) of these people pass away from pneumonia-related conditions.
The use of chest drainage systems is frequent in pulmonary and cardiothoracic procedures. There is an ongoing need for these devices because China is performing an increasing number of these procedures.
India is emerging as a highly lucrative chest drainage system manufacturing company market. This is due to rising prevalence of cardiovascular diseases, growing health awareness, and expanding healthcare infrastructure.
As per latest chest drainage system market analysis, sales of chest drainage systems in India are expected to thrive at 7.1% CAGR during the forecast period. By 2033, India thoracic drainage device market or chest drainage systems market is set to attain a valuation of US$ 176.50 million.
Increased surgical operations require Chest drainage systems for post-operative care and complication management. These include cardiothoracic surgeries, lung transplants, and trauma surgeries.
According to the Lancet Commission for Global Surgery (LCoGS), 100,000 persons in LMICs would need 5,000 procedures to address the surgical burden of disease. Few studies from LMICs estimate surgical burden based on the number of procedures.
The effectiveness, safety, and simplicity of chest drainage devices have all been improved thanks to ongoing developments in chest drainage system technology. Hospitals and healthcare organizations will likely embrace newer, more efficient chest drainage methods, thereby bolstering sales in the country.
Funding for healthcare facilities, including the purchase of chest drainage devices, may increase due to government initiatives and policies targeted at enhancing healthcare services in India. This will present lucrative growth opportunities for chest drainage system companies.
Japan is forecast to experience robust growth during the forecast period. As per the latest report, the country's demand for chest drainage systems is set to rise at 9.7% CAGR over the forecast period.
By 2033, Japan chest drainage system market size is projected to reach US$ 116.40 million. This is attributable to rising geriatric population, expanding healthcare infrastructure, and growing cases of respiratory diseases like COPD.
According to the World Economic Forum, more than 1 in 10 people in Japan are aged 80 or older. This rising geriatric population is expected to positively impact chest drainage system demand as elderly people are more prone to suffer from respiratory diseases requiring chest drainage.
Japan government is also investing rigorously in expanding the country’s healthcare infrastructure. This is expected to create new opportunities for chest drainage system manufacturers.
Sales of chest drainage systems in the United Kingdom are anticipated to thrive at 5.3% CAGR during the forecast period. By 2033, the market value of the United Kingdom chest drainage system is predicted to total US$ 48.94 million.
Several factors are expected to fuel chest drainage system sales in the United Kingdom. These include increasing cardiovascular disease incidence, favorable reimbursement policies, and rising healthcare spending.
Cardiovascular diseases are the leading cause of death in the United Kingdom. As per the British Heart Foundation, heart and circulatory disease cause over 160,000 deaths each year in the United Kingdom. This is positively impacting sales in the country.
Chest drainage systems treat several cardiovascular conditions, including hemothorax and pleural effusions. As the cases of cardiovascular diseases continue to rise, so does demand for chest drainage systems.
| Market Growth Outlook by Key Product | Value CAGR |
|---|---|
| Pleural Drainage Systems | 5.1% |
| Pleural Drainage Systems Kits | 7.9% |
| Pleural Drainage Systems Accessories | 10.2% |
As per the latest chest drainage system market analysis, pleural drainage systems segment is expected to remain the top-revenue generation product category. It is predicted to thrive at a CAGR of 5.1%, totaling a valuation of US$ 1,479.44 million by 2033.
Pleural drainage systems are gaining wider popularity among end users for draining the pleural space. The management of certain thoracic and respiratory disorders depends heavily on these systems.
Systems for pleural drainage are adaptable and can be utilized for various medical procedures and ailments. This fuels their demand across hospitals, clinics, and other end use sectors.
Pleural drainage systems are crucial in thoracic and respiratory treatment since they are not restricted to a particular procedure or technique. The ability of pleural drainage systems to effectively remove air, blood, or fluids from the pleural space is expected to fuel their demand through 2033.
Pleural Effusion to Hold a Prominent Market Share through 2033
| Market Growth Outlook by Key Indication | Value CAGR |
|---|---|
| Pleural Effusion | 4.5% |
| Hemothorax | 6.3% |
| Spontaneous Pneumothorax | 10.7% |
| Tension Pneumothorax | 9.5% |
| Traumatic Pneumothorax | 8.8% |
| Cardiac Tamponade | 7.3% |
| Coronary artery bypass grafting (CABG) Procedures | 4.8% |
| Open Heart Surgeries | 6.1% |
Based on indication, pleural effusion currently dominates the global chest drainage system industry, and the trend is expected to continue through 2033. This is due to rising prevalence of pleural effusion and growing need for treating this disease.
Pleural effusion is a relatively common medical illness in which fluid accumulation occurs between the parietal and visceral pleura. Numerous underlying factors and medical disorders can contribute to this illness. For instance,
According to the journal of the National Institutes of Health, in developed nations, the prevalence of pleural effusion is estimated to be 320 instances per 100,000 persons, with a variety of etiologies related to the frequency of underlying disorders.
Patients suffering from pleural effusion often opt for medical procedures for managing and treating this disease. This is expected to drive demand for chest drainage systems as they are employed to remove the fluid. Certain indwelling catheters also allow patients with recurrent effusions to be managed at home. Thus, increasing cases of pleural effusion will play a key role in boosting the chest drainage system industry.
As per the latest chest drainage system industry analysis, pleural effusion segment is projected to thrive at 4.5% CAGR during the assessment period. It is set to total a valuation of US$ 747.97 million by 2033.
Adoption of Chest Drainage Systems to Remain High in Hospitals
| Market Growth Outlook by Key End User | Value CAGR |
|---|---|
| Hospitals | 4.4% |
| Specialty Clinics | 8.9% |
| Ambulatory Surgical Centers | 5.6% |
The hospital segment is anticipated to dominate the target market with a share of around 42.2% in 2033. It is poised to exhibit a CAGR of 4.4% during the forecast period. This is attributable to rising number of hospitals, increasing patient flow, and adoption of chest drainage systems in these settings.
Hospitals are essential healthcare facilities that are crucial in detecting, treating, and managing cardiovascular disease. They provide various solutions and chest drainage systems for cardiovascular disease patients, such as diagnostic procedures, surgical interventions, and rehabilitation programs.
Modern medical technology, experienced cardiologists, and interdisciplinary teams are all found in hospitals, providing efficient patient care and illness control. Hospitals are crucial recipients of developments and innovations in the worldwide chest drainage system market. This is because of their central role in treating diseases such as pleural effusion, hemothorax, pneumothorax, etc.
Hospitals are investing in novel medical technologies and products to improve patient outcomes and boost the effectiveness of healthcare as a whole. This is expected to create growth prospects for chest drainage system manufacturers.
Geographic expansions are a priority for leading chest drainage systems companies. They work to create new product lines and expand their global consumer base. Top manufacturers of chest drainage systems are also implementing strategies like partnerships, acquisitions, mergers, and collaborations to solidify their market positions.
Recent Chest Drainage System Market Developments:
| Attribute | Details |
|---|---|
| Estimated Market Value (2023) | US$ 1,034.25 million |
| Projected Market Size (2033) | US$ 1,795.93 Million |
| Expected Growth Rate (2023 to 2033) | 5.7% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Latin America, East Asia, South Asia Pacific, Western Europe, Eastern Europe, Central Asia, Russia & Belarus, Balkan & Baltic Countries, Middle East & Africa. |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, Chile, Peru, Colombia, China, Japan, South Korea, India, Indonesia, Thailand, Philippines, Malaysia, Vietnam, Australia and New Zealand, United Kingdom, Germany, France, Spain, Italy, BENELUX, Nordic Countries, Poland, Hungary, Romania, Czech Republic, GCC Countries, Türkiye, Northern Africa, South Africa, Israel. |
| Key Market Segments Covered | Product, Indication, End-user, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Dynamics and Challenges, Strategic Growth Initiatives |
The global market was valued at around US$ 977.91 million in 2022.
In 2023, the global market size is set to reach US$ 1,034.25 million.
The global market is set to reach US$ 1,795.93 million by 2033.
With 82.4% share in 2033, pleural drainage systems will dominate the market.
The global market exhibited a 4.3% CAGR from 2017 to 2022.
Chest drainage system demand is expected to rise at 5.7% CAGR through 2033.
The success rate of chest drainage is between 70 to 90%.
Chest drainage system demand is expected to rise at 5.7% CAGR through 2033.
The goal of chest drainage system is to remove fluid, air, or blood from the pleural space.
The United States market size is set to reach US$ 478.19 million by 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends
4. Value-Added Insights
4.1. Product Assessment
4.1.1. Product Adoption Analysis
4.1.2. Product Mapping Analysis
4.2. Disease Epidemiology, By Country
4.2.1. Pleural Effusion
4.2.2. Hemothorax
4.2.3. Spontaneous Pneumothorax
4.2.4. Tension Pneumothorax
4.2.5. Traumatic Pneumothorax
4.2.6. Cardiac Tamponade
4.3. Installed Base Analysis by Region
4.4. Number of Coronary Artery Bypass Grafting (CABG) Procedures
4.5. Number of Open Heart Surgeries (OHS) Procedures
4.6. Regulatory Scenario
4.6.1. Regulatory Frameworks in United States
4.6.2. Regulatory Frameworks in Europe
4.6.3. Regulatory Frameworks in China
4.6.4. Regulatory Frameworks in Japan
4.6.5. Regulatory Frameworks in India
4.6.6. Regulatory Frameworks in Australia
4.6.7. Regulatory Frameworks in Middle East & Africa
4.7. PESTLE Analysis by Region
4.8. PORTER Analysis
4.9. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. R&D Funding By Region
5.1.3. R&D Funding By Country
5.1.4. Global Life Expectancy Outlook
5.1.5. Global Parent Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Prevalence of Respiratory Conditions
5.2.2. Advancements in Medical Technology
5.2.3. Surgical Procedures and Hospitalization Rates
5.2.4. Aging Population
5.2.5. Healthcare Infrastructure & Development
5.2.6. Infection Control Measures
5.2.7. Increasing Healthcare Spending
5.2.8. Patient-Centered Care
5.2.9. Competitive Landscape and Technological Innovation
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Volume Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Volume (Units) Analysis, 2017 to 2022
6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Assessment
7.1. Regional Pricing Analysis, By Product
7.2. Global Average Pricing Analysis Benchmark, By Product
7.3. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
8.3. Revenue Opportunity Scenario
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033
9.3.1. Pleural Drainage Systems
9.3.1.1. Traditional Pleural Drainage Systems
9.3.1.2. Digital Pleural Drainage Systems
9.3.2. Pleural Drainage Systems Kits
9.3.3. Pleural Drainage Systems Accessories
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) By Indication, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2023 to 2033
10.3.1. Pleural Effusion
10.3.2. Hemothorax
10.3.3. Spontaneous Pneumothorax
10.3.4. Tension Pneumothorax
10.3.5. Traumatic Pneumothorax
10.3.6. Cardiac Tamponade
10.3.7. Coronary Artery Bypass Grafting (CABG) Procedures
10.3.8. Open Heart Surgeries
10.4. Market Attractiveness Analysis By Indication
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) By End User, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033
11.3.1. Hospitals
11.3.2. Specialty Clinics
11.3.3. Ambulatory Surgical Centers
11.4. Market Attractiveness Analysis by End User
12. Global Market: Cross Sectional Analysis - Product Vs End User
12.1. Historical Market Size (US$ Million) By Product Vs End User, 2017 to 2022
12.2. Current and Future Market Size (US$ Million) Analysis and Forecast by Product Vs End User, 2023 to 2033
12.2.1. Pleural Drainage Systems
12.2.1.1. Hospitals
12.2.1.2. Specialty Clinics
12.2.1.3. Ambulatory Surgical Centers
12.2.2. Pleural Drainage Systems Kits
12.2.2.1. Hospitals
12.2.2.2. Specialty Clinics
12.2.2.3. Ambulatory Surgical Centers
12.2.3. Pleural Drainage Systems Accessories
12.2.3.1. Hospitals
12.2.3.2. Specialty Clinics
12.2.3.3. Ambulatory Surgical Centers
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Region, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2023 to 2033
13.3.1. North America
13.3.2. Latin America
13.3.3. East Asia
13.3.4. South Asia & Pacific
13.3.5. Western Europe
13.3.6. Eastern Europe
13.3.7. Central Asia
13.3.8. Russia & Belarus
13.3.9. Balkan & Baltic Countries
13.3.10. Middle East & Africa
13.4. Market Attractiveness Analysis by Region
14. North America Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. United States
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Indication
14.4.4. By End User
14.5. Market Trends
14.6. Drivers & Restraints Impact Analysis
14.7. Country-Wise Analysis
14.7.1. United States Market Analysis
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Product
14.7.1.2.2. By Indication
14.7.1.2.3. By End User
14.7.2. Canada Market Analysis
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Product
14.7.2.2.2. By Indication
14.7.2.2.3. By End User
15. Latin America Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Peru
15.3.1.5. Chile
15.3.1.6. Columbia
15.3.1.7. Rest of Latin America
15.3.2. By Product
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Indication
15.4.4. By End User
15.5. Market Trends
15.6. Drivers & Restraints Impact Analysis
15.7. Country-Wise Analysis
15.7.1. Brazil Market Analysis
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Product
15.7.1.2.2. By Indication
15.7.1.2.3. By End User
15.7.2. Mexico Market Analysis
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Product
15.7.2.2.2. By Indication
15.7.2.2.3. By End User
15.7.3. Argentina Market Analysis
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Product
15.7.3.2.2. By Indication
15.7.3.2.3. By End User
15.7.4. Peru Market Analysis
15.7.4.1. Introduction
15.7.4.2. Market Analysis and Forecast by Market Taxonomy
15.7.4.2.1. By Product
15.7.4.2.2. By Indication
15.7.4.2.3. By End User
15.7.5. Chile Market Analysis
15.7.5.1. Introduction
15.7.5.2. Market Analysis and Forecast by Market Taxonomy
15.7.5.2.1. By Product
15.7.5.2.2. By Indication
15.7.5.2.3. By End User
15.7.6. Columbia Market Analysis
15.7.6.1. Introduction
15.7.6.2. Market Analysis and Forecast by Market Taxonomy
15.7.6.2.1. By Product
15.7.6.2.2. By Indication
15.7.6.2.3. By End User
16. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Indication
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Indication
16.4.4. By End User
16.5. Market Trends
16.6. Drivers & Restraints Impact Analysis
16.7. Country-Wise Analysis
16.7.1. China Market Analysis
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Product
16.7.1.2.2. By Indication
16.7.1.2.3. By End User
16.7.2. Japan Market Analysis
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Product
16.7.2.2.2. By Indication
16.7.2.2.3. By End User
16.7.3. South Korea Market Analysis
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast by Market Taxonomy
16.7.3.2.1. By Product
16.7.3.2.2. By Indication
16.7.3.2.3. By End User
17. South Asia & Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Philippines
17.3.1.4. Thailand
17.3.1.5. Malaysia
17.3.1.6. Vietnam
17.3.1.7. Australia & New Zealand
17.3.1.8. Rest of South Asia
17.3.2. By Product
17.3.3. By Indication
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Indication
17.4.4. By End User
17.5. Market Trends
17.6. Drivers & Restraints Impact Analysis
17.7. Country-Wise Analysis
17.7.1. India Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Product
17.7.1.2.2. By Indication
17.7.1.2.3. By End User
17.7.2. Indonesia Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Product
17.7.2.2.2. By Indication
17.7.2.2.3. By End User
17.7.3. Philippines Market Analysis
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Product
17.7.3.2.2. By Indication
17.7.3.2.3. By End User
17.7.4. Thailand Market Analysis
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast by Market Taxonomy
17.7.4.2.1. By Product
17.7.4.2.2. By Indication
17.7.4.2.3. By End User
17.7.5. Malaysia Market Analysis
17.7.5.1. Introduction
17.7.5.2. Market Analysis and Forecast by Market Taxonomy
17.7.5.2.1. By Product
17.7.5.2.2. By Indication
17.7.5.2.3. By End User
17.7.6. Vietnam Market Analysis
17.7.6.1. Introduction
17.7.6.2. Market Analysis and Forecast by Market Taxonomy
17.7.6.2.1. By Product
17.7.6.2.2. By Indication
17.7.6.2.3. By End User
17.7.7. Australia & New Zealand Market Analysis
17.7.7.1. Introduction
17.7.7.2. Market Analysis and Forecast by Market Taxonomy
17.7.7.2.1. By Product
17.7.7.2.2. By Indication
17.7.7.2.3. By End User
18. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Germany
18.3.1.2. France
18.3.1.3. Spain
18.3.1.4. Italy
18.3.1.5. BENELUX
18.3.1.6. Nordic Countries
18.3.1.7. United Kingdom
18.3.2. By Product
18.3.3. By Indication
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Indication
18.4.4. By End User
18.5. Market Trends
18.6. Drivers & Restraints Impact Analysis
18.7. Country-Wise Analysis
18.7.1. Germany Market Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Product
18.7.1.2.2. By Indication
18.7.1.2.3. By End User
18.7.2. France Market Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. By Product
18.7.2.2.2. By Indication
18.7.2.2.3. By End User
18.7.3. Spain Market Analysis
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast by Market Taxonomy
18.7.3.2.1. By Product
18.7.3.2.2. By Indication
18.7.3.2.3. By End User
18.7.4. Italy Republic Market Analysis
18.7.4.1. Introduction
18.7.4.2. Market Analysis and Forecast by Market Taxonomy
18.7.4.2.1. By Product
18.7.4.2.2. By Indication
18.7.4.2.3. By End User
18.7.5. BENELUX Republic Market Analysis
18.7.5.1. Introduction
18.7.5.2. Market Analysis and Forecast by Market Taxonomy
18.7.5.2.1. By Product
18.7.5.2.2. By Indication
18.7.5.2.3. By End User
18.7.6. Nordic Countries Market Analysis
18.7.6.1. Introduction
18.7.6.2. Market Analysis and Forecast by Market Taxonomy
18.7.6.2.1. By Product
18.7.6.2.2. By Indication
18.7.6.2.3. By End User
18.7.7. United Kingdom Market Analysis
18.7.7.1. Introduction
18.7.7.2. Market Analysis and Forecast by Market Taxonomy
18.7.7.2.1. By Product
18.7.7.2.2. By Indication
18.7.7.2.3. By End User
19. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. Poland
19.3.1.2. Hungary
19.3.1.3. Romania
19.3.1.4. Czech Republic
19.3.1.5. Rest of Eastern Europe
19.3.2. By Product
19.3.3. By Indication
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Indication
19.4.4. By End User
19.5. Drivers & Restraints Impact Analysis
19.6. Country-Wise Analysis
19.6.1. Poland Market Analysis
19.6.1.1. Introduction
19.6.1.2. Market Analysis and Forecast by Market Taxonomy
19.6.1.2.1. By Product
19.6.1.2.2. By Indication
19.6.1.2.3. By End User
19.6.2. Hungary Market Analysis
19.6.2.1. Introduction
19.6.2.2. Market Analysis and Forecast by Market Taxonomy
19.6.2.2.1. By Product
19.6.2.2.2. By Indication
19.6.2.2.3. By End User
19.6.3. Romania Market Analysis
19.6.3.1. Introduction
19.6.3.2. Market Analysis and Forecast by Market Taxonomy
19.6.3.2.1. By Product
19.6.3.2.2. By Indication
19.6.3.2.3. By End User
19.6.4. Czech Republic Market Analysis
19.6.4.1. Introduction
19.6.4.2. Market Analysis and Forecast by Market Taxonomy
19.6.4.2.1. By Product
19.6.4.2.2. By Indication
19.6.4.2.3. By End User
20. Central Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
20.3.1. By Product
20.3.2. By Indication
20.3.3. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Product
20.4.2. By Indication
20.4.3. By End User
20.5. Drivers & Restraints Impact Analysis
21. Russia & Belarus Market Analysis 2017 to 2022 and Forecast 2023 to 2033
21.1. Introduction
21.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
21.3.1. By Product
21.3.2. By Indication
21.3.3. By End User
21.4. Market Attractiveness Analysis
21.4.1. By Product
21.4.2. By Indication
21.4.3. By End User
21.5. Drivers & Restraints Impact Analysis
22. Balkan & Baltic Countries Market Analysis 2017 to 2022 and Forecast 2023 to 2033
22.1. Introduction
22.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
22.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
22.3.1. By Product
22.3.2. By Indication
22.3.3. By End User
22.4. Market Attractiveness Analysis
22.4.1. By Product
22.4.2. By Indication
22.4.3. By End User
22.5. Drivers & Restraints Impact Analysis
23. Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
23.1. Introduction
23.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2017 to 2022
23.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
23.3.1. By Country
23.3.1.1. GCC Countries
23.3.1.2. Türkiye
23.3.1.3. Northern Africa
23.3.1.4. South Africa
23.3.1.5. Israel
23.3.1.6. Rest of Middle East & Africa
23.3.2. By Product
23.3.3. By Indication
23.3.4. By End User
23.4. Market Attractiveness Analysis
23.4.1. By Country
23.4.2. By Product
23.4.3. By Indication
23.4.4. By End User
23.5. Market Trends
23.6. Drivers & Restraints Impact Analysis
23.7. Country-Wise Analysis
23.7.1. GCC Countries Market Analysis
23.7.1.1. Introduction
23.7.1.2. Market Analysis and Forecast by Market Taxonomy
23.7.1.2.1. By Product
23.7.1.2.2. By Indication
23.7.1.2.3. By End User
23.7.2. Kingdom of Saudi Arabia Market Analysis
23.7.2.1. Introduction
23.7.2.2. Market Analysis and Forecast by Market Taxonomy
23.7.2.2.1. By Product
23.7.2.2.2. By Indication
23.7.2.2.3. By End User
23.7.3. Türkiye Market Analysis
23.7.3.1. Introduction
23.7.3.2. Market Analysis and Forecast by Market Taxonomy
23.7.3.2.1. By Product
23.7.3.2.2. By Indication
23.7.3.2.3. By End User
23.7.4. Northern Africa Market Analysis
23.7.4.1. Introduction
23.7.4.2. Market Analysis and Forecast by Market Taxonomy
23.7.4.2.1. By Product
23.7.4.2.2. By Indication
23.7.4.2.3. By End User
23.7.5. South Africa Market Analysis
23.7.5.1. Introduction
23.7.5.2. Market Analysis and Forecast by Market Taxonomy
23.7.5.2.1. By Product
23.7.5.2.2. By Indication
23.7.5.2.3. By End User
23.7.6. Israel Market Analysis
23.7.6.1. Introduction
23.7.6.2. Market Analysis and Forecast by Market Taxonomy
23.7.6.2.1. By Product
23.7.6.2.2. By Indication
23.7.6.2.3. By End User
24. Market Structure Analysis
24.1. Market Analysis by Tier of Companies
24.2. Market Share Analysis of Top Players (%)
25. Competition Analysis
25.1. Competition Dashboard
25.2. Competition Benchmarking
25.3. Branding and Promotional Strategies, By Key Manufactures
25.4. Key Development Analysis
25.5. Competition Deep Dive
25.5.1. Teleflex Incorporated
25.5.1.1. Overview
25.5.1.2. Product Portfolio
25.5.1.3. Key Financials
25.5.1.4. SWOT Analysis
25.5.1.5. Key Developments
25.5.1.6. Sales Footprint
25.5.1.7. Strategy Overview
25.5.1.7.1. Marketing Strategy
25.5.1.7.2. Product Strategy
25.5.1.7.3. Channel Strategy
25.5.2. B. Braun Melsungen AG
25.5.2.1. Overview
25.5.2.2. Product Portfolio
25.5.2.3. Key Financials
25.5.2.4. SWOT Analysis
25.5.2.5. Key Developments
25.5.2.6. Sales Footprint
25.5.2.7. Strategy Overview
25.5.2.7.1. Marketing Strategy
25.5.2.7.2. Product Strategy
25.5.2.7.3. Channel Strategy
25.5.3. Smith’s Medical (ICU Medical Inc.)
25.5.3.1. Overview
25.5.3.2. Product Portfolio
25.5.3.3. Key Financials
25.5.3.4. SWOT Analysis
25.5.3.5. Key Developments
25.5.3.6. Sales Footprint
25.5.3.7. Strategy Overview
25.5.3.7.1. Marketing Strategy
25.5.3.7.2. Product Strategy
25.5.3.7.3. Channel Strategy
25.5.4. Becton, Dickinson and Company
25.5.4.1. Overview
25.5.4.2. Product Portfolio
25.5.4.3. Key Financials
25.5.4.4. SWOT Analysis
25.5.4.5. Key Developments
25.5.4.6. Sales Footprint
25.5.4.7. Strategy Overview
25.5.4.7.1. Marketing Strategy
25.5.4.7.2. Product Strategy
25.5.4.7.3. Channel Strategy
25.5.5. Cardinal Health
25.5.5.1. Overview
25.5.5.2. Product Portfolio
25.5.5.3. Key Financials
25.5.5.4. SWOT Analysis
25.5.5.5. Key Developments
25.5.5.6. Sales Footprint
25.5.5.7. Strategy Overview
25.5.5.7.1. Marketing Strategy
25.5.5.7.2. Product Strategy
25.5.5.7.3. Channel Strategy
25.5.6. Redax S.p.A.
25.5.6.1. Overview
25.5.6.2. Product Portfolio
25.5.6.3. Key Financials
25.5.6.4. SWOT Analysis
25.5.6.5. Key Developments
25.5.6.6. Sales Footprint
25.5.6.7. Strategy Overview
25.5.6.7.1. Marketing Strategy
25.5.6.7.2. Product Strategy
25.5.6.7.3. Channel Strategy
25.5.7. Merit Medical Systems
25.5.7.1. Overview
25.5.7.2. Product Portfolio
25.5.7.3. Key Financials
25.5.7.4. SWOT Analysis
25.5.7.5. Key Developments
25.5.7.6. Sales Footprint
25.5.7.7. Strategy Overview
25.5.7.7.1. Marketing Strategy
25.5.7.7.2. Product Strategy
25.5.7.7.3. Channel Strategy
25.5.8. Getinge AB
25.5.8.1. Overview
25.5.8.2. Product Portfolio
25.5.8.3. Key Financials
25.5.8.4. SWOT Analysis
25.5.8.5. Key Developments
25.5.8.6. Sales Footprint
25.5.8.7. Strategy Overview
25.5.8.7.1. Marketing Strategy
25.5.8.7.2. Product Strategy
25.5.8.7.3. Channel Strategy
25.5.9. Rocket Medical plc.
25.5.9.1. Overview
25.5.9.2. Product Portfolio
25.5.9.3. Key Financials
25.5.9.4. SWOT Analysis
25.5.9.5. Key Developments
25.5.9.6. Sales Footprint
25.5.9.7. Strategy Overview
25.5.9.7.1. Marketing Strategy
25.5.9.7.2. Product Strategy
25.5.9.7.3. Channel Strategy
25.5.10. Grena Ltd.
25.5.10.1. Overview
25.5.10.2. Product Portfolio
25.5.10.3. Key Financials
25.5.10.4. SWOT Analysis
25.5.10.5. Key Developments
25.5.10.6. Sales Footprint
25.5.10.7. Strategy Overview
25.5.10.7.1. Marketing Strategy
25.5.10.7.2. Product Strategy
25.5.10.7.3. Channel Strategy
25.5.11. Sterimed Group
25.5.11.1. Overview
25.5.11.2. Product Portfolio
25.5.11.3. Key Financials
25.5.11.4. SWOT Analysis
25.5.11.5. Key Developments
25.5.11.6. Sales Footprint
25.5.11.7. Strategy Overview
25.5.11.7.1. Marketing Strategy
25.5.11.7.2. Product Strategy
25.5.11.7.3. Channel Strategy
25.5.12. pfm medical ag
25.5.12.1. Overview
25.5.12.2. Product Portfolio
25.5.12.3. Key Financials
25.5.12.4. SWOT Analysis
25.5.12.5. Key Developments
25.5.12.6. Sales Footprint
25.5.12.7. Strategy Overview
25.5.12.7.1. Marketing Strategy
25.5.12.7.2. Product Strategy
25.5.12.7.3. Channel Strategy
25.5.13. Medela AG
25.5.13.1. Overview
25.5.13.2. Product Portfolio
25.5.13.3. Key Financials
25.5.13.4. SWOT Analysis
25.5.13.5. Key Developments
25.5.13.6. Sales Footprint
25.5.13.7. Strategy Overview
25.5.13.7.1. Marketing Strategy
25.5.13.7.2. Product Strategy
25.5.13.7.3. Channel Strategy
25.5.14. Sinapi Biomedical
25.5.14.1. Overview
25.5.14.2. Product Portfolio
25.5.14.3. Key Financials
25.5.14.4. SWOT Analysis
25.5.14.5. Key Developments
25.5.14.6. Sales Footprint
25.5.14.7. Strategy Overview
25.5.14.7.1. Marketing Strategy
25.5.14.7.2. Product Strategy
25.5.14.7.3. Channel Strategy
25.5.15. ATMOS MedizinTechnik GmbH & Co. KG
25.5.15.1. Overview
25.5.15.2. Product Portfolio
25.5.15.3. Key Financials
25.5.15.4. SWOT Analysis
25.5.15.5. Key Developments
25.5.15.6. Sales Footprint
25.5.15.7. Strategy Overview
25.5.15.7.1. Marketing Strategy
25.5.15.7.2. Product Strategy
25.5.15.7.3. Channel Strategy
25.5.16. unimax medical systems inc.
25.5.16.1. Overview
25.5.16.2. Product Portfolio
25.5.16.3. Key Financials
25.5.16.4. SWOT Analysis
25.5.16.5. Key Developments
25.5.16.6. Sales Footprint
25.5.16.7. Strategy Overview
25.5.16.7.1. Marketing Strategy
25.5.16.7.2. Product Strategy
25.5.16.7.3. Channel Strategy
25.5.17. Ningbo Xinwell Medical Technology Co., LTD.
25.5.17.1. Overview
25.5.17.2. Product Portfolio
25.5.17.3. Key Financials
25.5.17.4. SWOT Analysis
25.5.17.5. Key Developments
25.5.17.6. Sales Footprint
25.5.17.7. Strategy Overview
25.5.17.7.1. Marketing Strategy
25.5.17.7.2. Product Strategy
25.5.17.7.3. Channel Strategy
25.5.18. Cook
25.5.18.1. Overview
25.5.18.2. Product Portfolio
25.5.18.3. Key Financials
25.5.18.4. SWOT Analysis
25.5.18.5. Key Developments
25.5.18.6. Sales Footprint
25.5.18.7. Strategy Overview
25.5.18.7.1. Marketing Strategy
25.5.18.7.2. Product Strategy
25.5.18.7.3. Channel Strategy
26. Assumptions and Acronyms Used
27. Research Methodology
Explore Healthcare Insights
View Reports
Chest Drainage System Market
